scholarly journals Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor

Virology ◽  
2003 ◽  
Vol 314 (1) ◽  
pp. 16-25 ◽  
Author(s):  
Hideki Aizaki ◽  
Seishi Nagamori ◽  
Mami Matsuda ◽  
Hayato Kawakami ◽  
Osamu Hashimoto ◽  
...  
Author(s):  
G. Carloni ◽  
S. Iacovacci ◽  
M. Sargiacomo ◽  
G. Ravagnan ◽  
A. Ponzetto ◽  
...  

2008 ◽  
Vol 148 (1-2) ◽  
pp. 174-181 ◽  
Author(s):  
Kyoko Murakami ◽  
Yasushi Inoue ◽  
Su-Su Hmwe ◽  
Kazuhiko Omata ◽  
Tomokatsu Hongo ◽  
...  

2004 ◽  
Vol 78 (3) ◽  
pp. 1448-1455 ◽  
Author(s):  
Jie Zhang ◽  
Glenn Randall ◽  
Adrian Higginbottom ◽  
Peter Monk ◽  
Charles M. Rice ◽  
...  

ABSTRACT CD81 has been described as a putative receptor for hepatitis C virus (HCV); however, its role in HCV cell entry has not been characterized due to the lack of an efficient cell culture system. We have examined the role of CD81 in HCV glycoprotein-dependent entry by using a recently developed retroviral pseudotyping system. Human immunodeficiency virus (HIV) pseudotypes bearing HCV E1E2 glycoproteins show a restricted tropism for human liver cell lines. Although all of the permissive cell lines express CD81, CD81 expression alone is not sufficient to allow viral entry. CD81 is required for HIV-HCV pseudotype infection since (i) a monoclonal antibody specific for CD81 inhibited infection of susceptible target cells and (ii) silencing of CD81 expression in Huh-7.5 hepatoma cells by small interfering RNAs inhibited HIV-HCV pseudotype infection. Furthermore, expression of CD81 in human liver cells that were previously resistant to infection, HepG2 and HH29, conferred permissivity of HCV pseudotype infection. The characterization of chimeric CD9/CD81 molecules confirmed that the large extracellular loop of CD81 is a determinant for viral entry. These data suggest a functional role for CD81 as a coreceptor for HCV glycoprotein-dependent viral cell entry.


Virology ◽  
2006 ◽  
Vol 351 (2) ◽  
pp. 381-392 ◽  
Author(s):  
Kyoko Murakami ◽  
Koji Ishii ◽  
Yousuke Ishihara ◽  
Sayaka Yoshizaki ◽  
Keiko Tanaka ◽  
...  

2010 ◽  
Vol 52 ◽  
pp. S255
Author(s):  
S. Lagaye ◽  
H. Shen ◽  
J. Gaston ◽  
M. Nascimbeni ◽  
M. Triyatni ◽  
...  

2014 ◽  
Vol 95 (2) ◽  
pp. 423-433 ◽  
Author(s):  
Shuanghu Liu ◽  
Ren Chen ◽  
Curt H. Hagedorn

Identification of the hepatitis C virus (HCV) JFH1 isolate enabled the development of infectious HCV cell culture systems. However, the relatively low virus titres and instability of some chimeric JFH1 reporter viruses restricts some uses of this system. We describe a higher-titre JFH1-EGFP reporter virus where the NS5A V3 region was replaced with the EGFP gene and adapted by serial passage in Huh7.5 cells. Six adaptive mutants were identified: one each in E2, P7 and NS4B, plus three in the NS5A region. These adaptive mutants increased the reporter virus titres to 1×106 immunofluorescent focus-forming units ml−1, which is the highest titre of JFH1-EGFP reporter virus reported to our knowledge. This chimeric virus did not lose EGFP expression following 40 days of passage and it can be used to test the activity of HCV antivirals by measuring EGFP fluorescence in 96-well plates. Moreover, this reporter virus allows living infected Huh7.5 cells in Matrigel three-dimensional (3D) cultures to be visualized and produces infectious viral particles in these 3D cultures. The chimeric NS5A-EGFP infectious JFH1 reporter virus described should enable new studies of the HCV life cycle in 3D cell cultures and will be useful in identifying antivirals that interfere with HCV release or entry.


1999 ◽  
Vol 104 (3) ◽  
pp. 239-248 ◽  
Author(s):  
Nafissa Rakba ◽  
Ahmed Melhaoui ◽  
Pascal Loyer ◽  
Jean Guy Delcros ◽  
Isabelle Morel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document